ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "clinical practice and tofacitinib"

  • Abstract Number: 451 • ACR/ARHP Annual Meeting 2015

    Efficacy of Tofacitinib in a Real World Setting Using the Database Jointman

    Sergio Schwartzman1, Keith Knapp2, Gary Craig3, Karen Ferguson4 and Howard Kenney5, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Arthritis Northwest, Spokane, WA, 3Discus Analytics, Inc., Spokane, WA, 4Arthritis Northwest PLLC., Spokane, WA, 5Rheumatology, Arthritis Northwest, Spokane, WA

    Background/Purpose: Tofacitinib (TFA) was approved for the treatment of rheumatoid arthritis (RA) in November of 2012. It is well accepted that patients studied in pharmaceutically…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology